Download: Understanding and overcoming intellectual property and patent law concerns when developing antibody therapeutics

MS

Download this presentation here >

The European Antibody Congress  brings together big pharma, big biotech, SME Biotech, academia, regulators and the wider service provider community to discuss the latest R&D and advances in the antibody space – across mAbs, ADCs, bispecifics, multispecifics, and protein scaffolds.

At the 2013 event, delegates were fortunate enough to hear from Dr Antonio Maschio, Partner, Maschio and Soames LLP,  who delivered the presentation ‘Understanding and overcoming intellectual property and patent law concerns when developing antibody therapeutics‘.

Download this presentation here >

If you’re interested in in learning more and engaging in discussion on mAbs, ADC’s, bispecifics and antibody biosimilars, you might want to check out the European Antibody Congress 2014 – preparations are in full swing! Make sure you’re networking with senior executives and opinion leaders across the antibody space.